Research Paper Volume 15, Issue 6 pp 2237—2274
A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease
Figure 4. The surface under the cumulative ranking curve for hemoglobin. (A) placebo/control; (B) ESAs; (C) daprodustat; (D) molidustat; (E) vadadustat; (F) roxadustat; (G) enarodustat.